The medication sunitinib, which is approved for the treatment of kidney cancer and gastrointestinal stromal cancer, may also help patients with metastatic melanoma according to an article in the March, 2012 issue of Clinical Cancer Research. This new medication uses a patient's own tumor cells to create a customized treatment plan.
The drug recently completed Phase II clinical trials. During the testing is was shown to be effective in treating skin cancer which occurs on parts of the body...
